| Entry |
|
|---|
| Name |
Levosimendan (USAN/INN);
Simdax (TN) |
|---|
| Formula |
C14H12N6O
|
|---|
| Exact mass |
280.1073
|
|---|
| Mol weight |
280.2847
|
|---|
| Structure |
|
|---|
| Class |
Cardiovascular agent
DG01703 Cardiotonic
DG01758 Pimobendan type cardiotonic
DG01507 Phosphodiesterase III inhibitor
DG01758 Pimobendan type cardiotonic
|
|---|
| Remark |
|
|---|
| Efficacy |
Cardiotonic, Phosphodiesterase inhibitor |
|---|
| Comment |
Treatment of congestive heart failure (cardiotonic, positive inotrope, vasodilator)
Calcium sensitizer
|
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C01 CARDIAC THERAPY
C01C CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
C01CX Other cardiac stimulants
C01CX08 Levosimendan
D04720 Levosimendan (USAN/INN)
Drug groups [BR:br08330]
Cardiovascular agent
DG01703 Cardiotonic
DG01758 Pimobendan type cardiotonic
D04720 Levosimendan
DG01507 Phosphodiesterase III inhibitor
DG01758 Pimobendan type cardiotonic
D04720 Levosimendan
Target-based classification of drugs [BR:br08310]
Enzymes
Hydrolases (EC3)
Phosphodiesterases
PDE3
D04720 Levosimendan (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 21
1 C8y C 21.3500 -17.5000
2 C8x C 21.3500 -18.9000
3 C8x C 20.1600 -19.6000
4 C8y C 18.9000 -18.9000
5 C8x C 18.9000 -17.5000
6 C8x C 20.1600 -16.8000
7 C2y C 17.7100 -19.6000
8 N2x N 17.7100 -21.0000
9 N1x N 16.4500 -21.7000
10 C5x C 15.2600 -21.0000
11 C1x C 15.2600 -19.6000
12 C1y C 16.4500 -18.9000
13 N1b N 22.5400 -16.8000
14 O5x O 14.0447 -21.6951
15 C1a C 16.4328 -17.5001
16 N2b N 23.7581 -17.4901
17 C2c C 24.9395 -16.7950
18 C3b C 26.1449 -17.4780
19 C3b C 24.9281 -15.4000
20 N3a N 24.9281 -14.0000
21 N3a N 27.3573 -18.1780
BOND 22
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 4 7 1
8 7 8 2
9 8 9 1
10 9 10 1
11 10 11 1
12 11 12 1
13 7 12 1
14 1 13 1
15 10 14 2
16 12 15 1 #Up
17 13 16 1
18 16 17 2
19 17 18 1
20 17 19 1
21 19 20 3
22 18 21 3
|
|---|
